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Purpose: To provide a new insight on a novel safe cardiac radioablation using deep inspiration 
breath-hold (DIBH) to reduce gastrointestinal dose. 
Materials and Methods: For treating incessant ventricular tachycardia (VT) originated from left ven-
tricle inferior scar abutting the stomach, a target delineation and treatment planning for cardiac ra-
dioablation was performed. With four different computed tomography (CT) scan protocols—DIBH, full 
expiration breath-hold, four-dimensional (4D) CT without and with abdominal compression, the dis-
tances between the target and the stomach were compared. 
Results: Among the protocols, the CT scan with DIBH showed largest distance between the target 
and the stomach and selected for the treatment planning. The prescribed dose was 25 Gy in a single 
fraction, and satisfactory dosimetric parameters were achieved with the DIBH. The patient was suc-
cessfully treated with the DIBH, and experienced no acute toxicity. 
Conclusion: To gain the best benefit from cardiac radioablation, understanding the possible toxicity 
in the adjacent organs is crucial. By moving the heart with thoraco-diaphragmatic movement by 
DIBH, the target could be physically separated from the stomach. 
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Introduction 
Noninvasive cardiac radioablation, delivered with stereotactic body 
radiotherapy (SBRT), was recently introduced as a treatment option 
for life threatening refractory ventricular tachycardia (VT) [1,2]. De-
pending on location of the target within the ventricle, a variety of 
organs-at-risk such as the esophagus, stomach, and bowel could 
be exposed to high doses of radiation. Although few high-grade 
late complications have been described [3], one patient on the EN-
CORE-VT trial (electrophysiology-guided noninvasive cardiac ra-
dioablation for ventricular tachycardia) developed a grade 3 gas-
tropericardial fistula 2-year after treatment [4], and another pa-
tient treated by Ostrava group developed a grade 5 esophageal fis-
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tula [5]. Therefore, the radiation risk of luminal internal organs in 
particular should be considered during treatment planning. 
Cardiac radioablation targets along the inferior wall of the ven-
tricle represent a particular emerging challenge due to their inher-
ent proximity to structures such as the esophagus, stomach, and 
bowel. At present, no specific techniques have been described to 
improve dosimetry for these complex targets. Furthermore, the 
heart does not stick to adjacent internal organs, but moves and ro-
tates with thoraco-diaphragmatic movement. Herein, we report a 
successful cardiac radioablation using the deep inspiration breath-
hold (DIBH) technique to minimize toxicity to the stomach during 
cardiac radioablation. 
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Materials and Methods 
1. Patient information and target definition 
With Institutional Review Board approval of Seoul National Univer-
sity Hospital (No. 2011-151-1175), cardiac radioablation was con-
sidered for the medically intractable VT because catheter ablation 
was contraindicated due to the previous cardiac valve surgeries. 
Informed consent of the patient for radiotherapy under clinical trial 
(blinded) [6] was obtained. The detailed patient information was 
described in Supplement A. 
Based on the 12-leads electrocardiography (Fig. 1), the VT seemed 
to originate from the mid-inferior left ventricle (LV). Cardiac mag-
netic resonance imaging (MRI) confirmed a transmural and suben-
docardial delayed enhancement in the mid-inferior and inferolateral 
segments, indicating myocardial scarring (Fig. 2). 
2. CT simulation and target delineation 
The patient underwent the four different computed tomography 
(CT) scans with slice thickness of 2 mm using the Brilliance CT Big 
Bore system (Phillips, Cleveland, OH, USA): (1) DIBH, (2) full expira-
tion breath-hold, (3) four-dimensional (4D) CT without abdominal 
compression, and (4) 4D-CT with abdominal compression. The res-
piration-gated 10 phase 4D-CT images were acquired using the 
Real-time Position Management system (RPM; Varian Medical Sys-
tems, Palo Alto, CA, USA). The VT focus shown in electrocardiogra-
phy and cardiac MRI was delineated as gross target volume (GTV). 
The margin for clinical target volume (CTV) was 1 cm, and 0.5 cm 
was additionally expanded for planning target volume (PTV). Gen-
erally, electrophysiological mapping could provide more accurate 
information on the location of the VT focus, however in this case, 
invasive 3D mapping could not be performed due to patient’s pre-
vious surgical history. Therefore, the CTV was extended to account 
for possible spread of myocardial scar at border lesions, which 
might have not been visualized on MRI. To further limit the radia-
tion dose to the stomach, the stomach planning organ-at-risk vol-
ume (PRV) was determined as stomach plus 0.5 cm. Of the four 
scans, the largest distance between the stomach and LV scar was 
achieved on the DIBH scan (Fig. 3). The closest distance between 
the stomach and the PTV was 0.67 cm in DIBH, 0.49 cm in average 
image of 4D CT without abdominal compression and 0 cm (over-
lapped) in full expiration breath-hold and average image of 4D CT 
with abdominal compression. Meanwhile, GTV, CTV, PTV, stomach, 
and stomach PRV delineation on the CT scans with full expiration, 
average intensity 4D CT image (4DCT-AVG) with abdominal com-
pression, and 4DCT-AVG without abdominal compression showed 
abutment or overlap of PTV and stomach PRV. Therefore, treatment 
Fig. 1. Electrocardiography of ventricular tachycardia.
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Fig. 2. Myocardial scar on cardiac magnetic resonance imaging. Ao, aorta; pAV, prosthetic aortic valve; LV, left ventricle; RV, right ventricle; Sto, 
stomach.
Fig. 3. (A) Representative coronal images showing largest distance between the clinical target volume (orange), planning target volume (purple) 
and the stomach (yellow) and stomach planning organs-at-risk volume (light green) in deep inspiration breath-hold (DIBH, left) and full expira-
tion breath-hold (right). (B) Axial images showing shortest distance in DIBH, full expiration breath-hold, average image of four-dimensional 
computed tomography with and without abdominal compression.
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Cardiac radioablation using DIBH
planning was performed using the DIBH scan. 
3. VMAT planning 
The prescribed dose to the PTV was 25 Gy in a single fraction. The 
Eclipse system (Varian Medical Systems) was used for treatment 
planning, and volumetric modulated arc therapy (VMAT) planning 
was performed using three half arcs with a 10-MV flattening fil-
ter-free beam (Fig. 4). The plan was optimized to achieve a PTV 
coverage of V98% =  100% while applying maximum dose constraint 
to stomach PRV of 10 Gy. The maximum dose within the PTV was 
113% of the prescribed dose. The actual maximum dose to the 
stomach PRV and stomach was 14.6 and 9.8 Gy, respectively. 
Results 
1. Cardiac radioablation using DIBH 
The Varian TrueBeam linear accelerator (Varian Medical Systems) 
was used for cardiac radioablation. Prior to on-board cone-beam 
CT (CBCT) acquisition, fluoroscopy guidance tracking using im-
plantable cardioverter defibrillator (ICD) lead tip and prosthetic 
valve contour projection was performed. As the patient could toler-
ate a breath-hold state for approximately 20 seconds, CBCT was 
performed with three DIBHs, and the treatment was performed 
with multiple DIBHs. CBCT matching was performed using contours 
of the cardiac outline and adjacent organs, including the bronchus 
and bones. The patient could successfully reproduce DIBH by 
coaching. Under breath-hold mode, the beam was manually turned 
on only when the inspiration level was achieved (Fig. 5). Total mon-
itor unit (MU) was 2175 + 3171 + 3431 MU and delivered at 600 
MU/min. The total beam-on time was 15.2 minutes. 
The patient kept fasting before radioablation and no preventive 
prescription was given to the patient. 
2. Outcome 
Within 2-day after radiotherapy, VT burden decreased by 46.4% 
except single ICD therapy. Afterwards, the patient experienced no 
Fig. 4. Volumetric modulated arc therapy planning using deep inspiration breath-hold computed tomography.
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VT event or abdominal discomfort. Esophagogastroduodenoscopy is 
not planned for routine surveillance due to the patient’s medical 
comorbidities and will be performed when the patient has related 
symptoms. 
Discussion and Conclusion 
To the best of our knowledge, this is the first report to show that 
gastrointestinal irradiation could be minimized during cardiac ra-
dioablation in the inferior LV using a tailored radiotherapy with 
DIBH. We tried DIBH to overcome the possibility of a gastropericar-
dial fistula during irradiation reported from ENCORE-VT trial [1,4]. 
In this case, the target was the inferior LV (the portion of the heart 
closest to the stomach) [7]. The Ostrava group reported one grade 
5 esophagi-pericardial fistula in abstract form, therefore the de-
tailed information would be available later [5]. 
Several studies have attempted to reduce the heart dose by DIBH 
in cases of gastric lymphoma and breast cancer [8-10]. The DIBH 
technique is gated irradiation during deep inspiration, investigated 
by several studies, mostly focused on reducing the dose to the 
heart. In this case, we conversely used DIBH to reduce the radiation 
dose to the stomach for cardiac radioablation. During deep inspira-
tion, the heart descends with the diaphragm and becomes more 
elongated. Additionally, an inspiratory intrathoracic pressure de-
crease causes a LV volume decrease [11]. Furthermore, the heart 
rotates medially because part of the pericardium attaches to the 
diaphragm [12]. Consequently, the LV is physically separated from 
the stomach, which moves downward with the diaphragm during 
deep inspiration. 
RT-related gastrointestinal toxicities include bleeding, ulceration, 
perforation, or fistula [13]. The tolerance dose for grade ≥2 gastro-
duodenal toxicity in SBRT is variable among studies [14-17]; how-
ever, most of the studies have applied fractionated SBRT. The 
Quantitative Analyses of Normal Tissue Effects in the Clinic report 
recommended V22.5 to be minimized and ideally constrained to 
<4% [18]. This constraint was used for a study in Stanford Univer-
sity, and the authors reported a dosimetric model of duodenal tox-
icity after a single-fraction SBRT for pancreatic cancer and report-
ed that V15 ≥  9.1 cm
3, V20 ≥  3.3 cm
3, and Dmax ≥  23 Gy were relat-
ed to increased duodenal toxicity [15]. According to these data, our 
dosimetric parameters satisfied dose constraints far below the cut-
off values.  
Fig. 5. Deep inspiration breath-hold using Real-time Position Management system. The yellow box represents beam-on state.
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The possible short-term and long-term toxicity data should be 
monitored after cardiac radioablation. Furthermore, it is important 
to predict and prevent possible complications depending on the 
target location. In preclinical data, bronchomediastinal fistula, con-
duction block, or sudden death have been reported [19-21]. In clin-
ical studies, some patients experienced radiation pneumonitis, 
pericarditis, or pericardial effusion that were mostly managed with 
observation or medications, except gastrointestinal fistula. Overall, 
most patients showed a good safety profile associated with irradia-
tion [22]. Therefore, cardiac radioablation is potentially safe for in-
tractable VT patients. To improve the safety of cardiac radioabla-
tion, using DIBH in VT patients would be applicable in patients with 
the target near the stomach, which could be mostly inferior LV, but 
it would depend on each patient’s anatomical differences. It is es-
sential to consider tailored radiotherapy techniques in each case 
and the DIBH technique would be one option for securing the dis-
tance between the heart and stomach. 
In conclusion, to gain the best benefit from cardiac radioablation 
for fatal VTs, understanding the possible toxicity in adjacent organs 
is crucial. Successful treatment could be achieved by applying the 
DIBH technique while saving the stomach from excessive radiation, 
which could have caused serious complications. 
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